Laboratori 2019/2020 - Terapia Genica e Cellulare
5 research fellowships GCT-SR-TIGET.
In the online application form, if interested, the candidate must select the projects of interest, from one to all, among those named GCTSR-T and proposed below
A candidate awarded a GCT-SR-TIGET must choose one of the projects selected in the application form. In case of none of these projects will be available, the candidate will re-enter the ranking list for the subsequent assignment phases according to the procedures set out in the call for applications (see art. 5.3.1).
__________________________________________________________
9 three-year fellowships FCSR-Fronzaroli intended for those candidates who will select one of the accredited projects for this fellowship.
The preference for an FCSR-Fronzaroli fellowship must be indicated in the online application form, as per art. 5 of the Call for applications.
Candidates assigned a FCSR-Fronzaroli fellowship or of a free fellowship must choose the research project from those offered for the 1st choice Curriculum..
After the second phase of assignment, all the projects FCSR-Fronzaroli, which WERE NOT chosen by the candidates awarded these fellowships, could be selected during subsequent phases by all the other candidates.
CANTORE ALESSIO - GCTSR-T1 / FCSR Fronzaroli
Unit: Gene transfer technology and new gene therapy strategies
GCTSR-T1: Improving the efficacy and safety of liver-directed lentiviral gene therapyCOLTELLA NADIA - FCSR Fronzaroli
Unit: Targeted Cancer Gene Therapy
Gene-therapy mediated reprogramming of the tumor microenvironment by local release of immunomodulatory cytokinesFERRARI GIULIANA - GCTSR-T2 / FCSR Fronzaroli
Unit: Gene Transfer Into Stem Cell
GCTSR-T2: Defining hematopoietic stem cell function and interactions within the bone marrow niche in BTHALGENTNER BERNHARD - GCTSR-T3 / FCSR Fronzaroli
Unit: Translational Stem Cell & Leukemia Research
GCTSR-T3: New cell therapy approaches for acute leukemiaGREGORI SILVIA - GCTSR-T4 / FCSR Fronzaroli
Unit: Mechanisms of Peripheral Tolerance
GCTSR-T4: Engineered human dendritic cell immunotherapy to induce/restore tolerance in T-cell mediated diseasesGRITTI ANGELA - FCSR Fronzaroli
Unit: Gene/Neural Stem Cell Therapy for Lysosomal Storage Diseases
Development of chimeric lysosomal enzymes with improved bioavailability to advance gene therapy strategies for globoid cell leukodystrophyKAJASTE-RUDNITSKI ANNA - GCTSR-T5 / FCSR Fronzaroli
Unit: Retrovirus-Host Interactions and Innate Immunity to Gene Transfer
GCTSR-T5: Dissecting Innate Immune Barriers to Efficient Hematopoietic Stem Cell Gene EngineeringMONTINI EUGENIO - GCTSR-T6 / FCSR Fronzaroli
Unit: Safety of gene therapy and insertional mutagenesis
GCTSR-T6: Dissecting the non-cell autonomous effects of oncogene activation on hematopoiesisSQUADRITO MARIO LEONARDO - FCSR Fronzaroli
Unit: Targeted Cancer Gene Therapy
In Vivo Genetic Engineering To Potentiate Cancer Immunotherapy And Promote Anti-Tumor Immune ActivationVILLA ANNA - GCTSR-T7 / FCSR Fronzaroli
Unit: Pathogenesis and Treatment of Immune and Bone Diseases
GCTSR-T7: Dissection of immune dysregulation in RAG deficiency and development of novel gene correction strategies